【摘要】 目的:探讨认知疗法对躯体形式障碍的治疗效果。方法:将符合CCMD-3诊断标准的58例躯体形式障碍患者随机分为治疗组和对照组,治疗组给予帕罗西汀配合认知疗法,对照组给予帕罗西汀治疗,疗程12周;采用症状自评量表(SCL-90)进行临床疗效评定。结果:治疗的4、8、12周末,SCL-90评分治疗组优于对照组,两组比较差异无显著性(P>0.05),但治疗组在早期控制靶症状,改善不良情绪方面优于对照组。结论:帕罗西汀配合认知疗法治疗躯体形式障碍是较有效的治疗方法。更多还原

【Abstract】 Objective:To explore the effect of recognition therapy combined with paroxetine on the patient with body disorders. Methods:58 patients who met CCMD-3 for body disorders were assigned to therapeutic group(n=29) and control group(n=29).Therapeutic group were given paroxetine in addition to recognition therapy,and control group were give paroxetine only for 12 weeks.The clinical effect was assessed with scl-90 at the end of 4 week,8 week,and 12 week.Results: Assessment of therapeutic group was higher than that in control group and recognition therapy combined with paroxetine can quickly treat target symptoms and improve ill emotion.Conclusions: Recognition therapy combined with paroxetine is an effective treatment for patients with body disorders.更多还原